WDR69 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the WDR69 protein, a member of the WD repeat-containing protein family. WDR69 is characterized by its WD40 repeat domains, which facilitate protein-protein interactions and the formation of multiprotein complexes essential for a range of cellular processes. WD repeat proteins like WDR69 are known to participate in signal transduction, cell division, and chromatin remodeling, often acting as scaffolds that coordinate the assembly of molecular complexes. In the case of WDR69, its exact role is still being elucidated, but it is thought to be involved in processes related to gene regulation, protein trafficking, and possibly chromosomal maintenance. By inhibiting WDR69, researchers can disrupt its involvement in these pathways, leading to alterations in cellular functions that depend on precise molecular interactions.
The mechanism of action for WDR69 inhibitors typically involves binding to the WD40 repeat domains or other critical regions of the WDR69 protein, preventing it from forming the necessary interactions with other proteins in the cell. This inhibition can interfere with cellular processes that rely on WDR69's role in assembling and stabilizing multiprotein complexes, potentially impacting activities such as gene expression, protein degradation, and chromatin structure regulation. WDR69 inhibitors are important tools for researchers aiming to understand the specific biological functions of this protein and its contribution to cellular architecture and regulation. Through selective inhibition of WDR69, these compounds provide valuable insights into the broader role of WD repeat-containing proteins in maintaining the balance and organization of molecular networks within cells, highlighting their significance in cellular communication and structural integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, a kinase upstream in signaling pathways where WDR69 may be involved, altering cellular responses and WDR69 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, altering stress response pathways that can modulate WDR69-related functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can alter transcriptional regulation and cellular stress responses involving WDR69. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, affecting signaling pathways and potentially altering WDR69 function due to changes in cellular context. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a key regulator of cell growth and proliferation, possibly affecting WDR69-related processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, impacting the MAPK/ERK pathway and influencing cellular functions where WDR69 operates. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, impacting signaling cascades and potentially modulating WDR69 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, affecting cytoskeletal organization and cell motility, processes in which WDR69 may be implicated. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibits V-ATPase, affecting vesicular trafficking and pH regulation, potentially influencing WDR69 function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), altering calcium signaling and possibly affecting WDR69. | ||||||